NEURAMIS
Pharmaceuticals, namely, hyaluronate acid and modified hyaluronate acid for use as a soft tissue filler for treatment of damaged tissue; specialized medical capsules, namely, self-contained ampules sold filled with pharmaceuticals for use in dispensing the same in the nature of prepackaged hyaluronic acid and derivatives thereof alone, and in combination with other polysaccharide for pharmaceutical purposes in particular starch, cellulose esters, and with and without lidocaine; dermal tissue ...
Registered · April 8, 2022 · 97353963 ·